ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ikonisys SA

Ikonisys SA (ALIKO)

1.41
0.00
( 0.00% )
Updated: 03:47:01

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.41
Bid
1.36
Ask
1.41
Volume
260
1.40 Day's Range 1.41
1.25 52 Week Range 1.76
Market Cap
Previous Close
1.41
Open
1.41
Last Trade
59
@
1.41
Last Trade Time
03:47:01
Financial Volume
-
VWAP
-
Average Volume (3m)
8,359
Shares Outstanding
10,451,424
Dividend Yield
-
PE Ratio
-6.50
Earnings Per Share (EPS)
-0.22
Revenue
644k
Net Profit
-2.27M

About Ikonisys SA

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Paris, Paris, Fra
Founded
-
Ikonisys SA is listed in the Surgical,med Instr,apparatus sector of the Euronext with ticker ALIKO. The last closing price for Ikonisys was 1.41 €. Over the last year, Ikonisys shares have traded in a share price range of 1.25 € to 1.76 €.

Ikonisys currently has 10,451,424 shares outstanding. The market capitalization of Ikonisys is 14.74 € million. Ikonisys has a price to earnings ratio (PE ratio) of -6.50.

ALIKO Latest News

The Ikonisys Group Unveils its New Vision and Strategy Under the Brand “ALIKO SCIENTIFIC”

Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for...

Le Groupe Ikonisys remporte un contrat public majeur en Italie pour son microscope robotique Ikoniscope20

Regulatory News: Ikonisys SA (Euronext Growth Paris : ALIKO), une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée...

Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé

Regulatory News: Ikonisys SA (Euronext Growth Paris : ALIKO), une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée...

Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis...

Le Groupe Ikonisys renouvelle son accord en tant que représentant autorisé et importateur européen de la technologie d’immunohistochimie en temps réel certifiée CE-IVD de Novodiax pour les diagnostics oncologiques ...

  Regulatory News: Ikonisys SA (Paris:ALIKO): Le Groupe Ikonisys renouvelle son accord en tant que représentant autorisé et importateur européen de la technologie d’immunohistochimie en temps...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-3.424657534251.461.471.3228961.42688111DE
4-0.06-4.081632653061.471.481.28116331.4211976DE
12-0.16-10.19108280251.571.621.2883591.44810347DE
26-0.01-0.7042253521131.421.711.2881731.49022143DE
52-0.27-16.07142857141.681.761.2575871.48108329DE
156-1.44-50.52631578952.853.11.1440241.5846147DE
260-2.73-65.94202898554.144.71.1442061.88835182DE

ALIKO - Frequently Asked Questions (FAQ)

What is the current Ikonisys share price?
The current share price of Ikonisys is 1.41 €
How many Ikonisys shares are in issue?
Ikonisys has 10,451,424 shares in issue
What is the market cap of Ikonisys?
The market capitalisation of Ikonisys is EUR 14.74M
What is the 1 year trading range for Ikonisys share price?
Ikonisys has traded in the range of 1.25 € to 1.76 € during the past year
What is the PE ratio of Ikonisys?
The price to earnings ratio of Ikonisys is -6.5
What is the cash to sales ratio of Ikonisys?
The cash to sales ratio of Ikonisys is 22.89
What is the reporting currency for Ikonisys?
Ikonisys reports financial results in EUR
What is the latest annual turnover for Ikonisys?
The latest annual turnover of Ikonisys is EUR 644k
What is the latest annual profit for Ikonisys?
The latest annual profit of Ikonisys is EUR -2.27M
What is the registered address of Ikonisys?
The registered address for Ikonisys is 62 RUE DE CAUMARTIN, PARIS, PARIS, 75009
What is the Ikonisys website address?
The website address for Ikonisys is www.ikonisys.com
Which industry sector does Ikonisys operate in?
Ikonisys operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
14.80 €
(1,984.51%)
2.07k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.80 €
(37.68%)
2.33M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
107.28k
ALCYBCybergun
0.0001 €
(-50.00%)
111.56M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ALEUPEuroplasma
0.0428 €
(-11.57%)
3.54M
ATOAtos SE
0.0027 €
(17.39%)
2.59B
ALCYBCybergun
0.0001 €
(-50.00%)
111.56M
NEOENNeoen SA
39.77 €
(0.58%)
81.34M
BCPBanco Comercial Portugues SA
0.4593 €
(1.84%)
65.98M
ALHPIHopium SA
0.005 €
(0.00%)
19.08M

Discussion

View Full Feed
LowFloatLopes LowFloatLopes 59 seconds ago
Just averaged up ..grabbed some .28s ... Holding 30000 now .082 average LFG!!!
LILMF
tigerpac tigerpac 1 minute ago
This is nothing more than a P&D. Trade it accordingly.
MLGO
gdog gdog 1 minute ago
well we may not beable to afford another play after this one lol
NLST
SkyLimit2022 SkyLimit2022 2 minutes ago
Baxers,

Great post! Very interesting and valid points—ran your post through AI for some follow-up discussion…

“Yes, this is a reasonable argument, and it is well-constructed for advocating DCVax’s potential benefits to the National Institute for Health and Care Excel
NWBO
vdog1776 vdog1776 2 minutes ago
Where are our saviors? Someone needs to warn these people!!!
VXIT
Fdc4 Fdc4 2 minutes ago
I don’t think they purposely do something. They definitely have their agenda, trust me, it doesn’t match with ours. I believe this recent acquisition made by Mr. Blum delayed or complicated things with FINRA a little bit. I am suspecting that due to such, more paperwork was asked… Note: I am just sp
SMCE
vlispxpert vlispxpert 2 minutes ago
started BKYI, looking for 1.11 back test to munch
BKYI
JRoon71 JRoon71 2 minutes ago
OK, so maybe they are suggesting that the "finished" market opportunity is more than just finished IPE (Vascepa and generic IPE).

Again, just trying to understand where $1.2B in 2023 comes from, and what the $2.8B in 2032 includes.

It seems that the combination of Vasc
AMRN
Hardazoak Hardazoak 2 minutes ago
Benny made thousands extremely wealthy, including myself. I am very grateful to him. He is going to take us to 8 dollar land now. Can't wait.
AABB
Denisk Denisk 2 minutes ago
API
An active pharmaceutical ingredient (API) is the component of an over-the-counter (OTC) or prescription medication that produces its intended health effects. If a prescription drug has a generic, its name is the same as its API. Combination therapies have more than one active ingredient,
API
ThSeeker ThSeeker 2 minutes ago
There has been significant news recently but it is not well distributed.
https://www.accesswire.com/957824/alset-ai-announces-strategic-investment-in-real-estate-ai-innovator-blueprint-ai-expanding-its-portfolio-of-artificial-intelligence-companies
ALSCF
Mr. C Mr. C 2 minutes ago
These few hundred share buys at $0.13 look like straight manipulation
TGLO
konshe konshe 2 minutes ago
RDGL pull back is over, ready to continue going up, can we see 0.50 next Month- ,January 2025? I feel very possible with another two news and two gap up. let's see.
RDGL
Nebuchadnezzar Nebuchadnezzar 2 minutes ago
BOTY RITE
BOTY
Axeman Axeman 2 minutes ago
Not quite...slow your roll. 🤣
HLLK
Doubledown75 Doubledown75 3 minutes ago
Ya think?? lol
We are trading at 0.0075 pre RS now, and we don't even go bankrupt. Biolase gave us Carolyn Beaver as BOD though. Don't think it was a present for the shareholder either;) 
SONX
crescentmotor crescentmotor 3 minutes ago
Morning shakedown by MMs. Should reverse by late afternoon.


The shorts have been very aggressively shorting with high volume this morning. The mojo from the MAA acceptance has now faded so we'll have to see where AVXL finds a new support level. Overall market being down toda
AVXL
marcis marcis 3 minutes ago
Flippers want back in
RDAR
manibiotech manibiotech 3 minutes ago
Thanks 
NWBO
georgie18 georgie18 3 minutes ago
HUBC....68...🥳...Off my .39 Alert...

georgie18

Member Level
Re: georgie18 post# 668802

Friday, December 27, 2024 8:39:10 AM

Post#
669137
of 669178
HUBC...58...🥳...Off my .39 Alert...
HUBC
QueenWitch42 QueenWitch42 3 minutes ago
UP..
https://i.postimg.cc/nzrHFLPr/LX.gif
LX
georgie18 georgie18 3 minutes ago
HUBC....68...🥳...Off my .39 Alert...

georgie18

Member Level
Re: georgie18 post# 668802

Friday, December 27, 2024 8:39:10 AM

Post#
669137
of 669178
HUBC...58...🥳...Off my .39 Alert...
HUBC
Here Today Here Today 3 minutes ago
The way management has been handling the stock and company, they have driven away most if not all retail investors. Now all you have left are these shark investment companies that will bleed the company down with bad loans while diluting the shares to nothing again- hence no interest from retail any
RNAZ
georgie18 georgie18 3 minutes ago
HUBC....68...🥳...Off my .39 Alert...

georgie18

Member Level
Re: georgie18 post# 668802

Friday, December 27, 2024 8:39:10 AM

Post#
669137
of 669178
HUBC...58...🥳...Off my .39 Alert...
HUBC